Kanamycin A Sulfate
규격
25389-94-0CAS 번호
223-347-1EC 번호
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acidIUPAC 명칭
C18H38N4O15S화학식
582.6 g/mol분자량
Kanamycin A sulfate; Kanamycin A sulphate; DTXSID1047524; J80EX28SMQ; EINECS 223-347-1; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid; CHEBI:6109; DTXCID9027524; KANAMYCIN A SULFATE [MI]; KANAMYCIN SULFATE [USP-RS]; KANAMYCIN SULFATE [USP MONOGRAPH]; KANAMYCIN MONOSULFATE [EP MONOGRAPH]; KANAMYCIN SULFATE (USP-RS); KANAMYCIN SULFATE (USP MONOGRAPH); D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL(1->4))-2-DEOXY-, SULFATE (1:1) (SALT); D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL(1->4))-2-DEOXY-, SULPHATE (1:1) (SALT); D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt); KANAMYCIN MONOSULFATE (EP MONOGRAPH); Kanaplex; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxyoxane-3,4,5-triol;sulfuric acid; RefChem:792626; 223-347-1; 613-414-7; D-STREPTAMINE, O-3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL(1->6)-O-(6-AMINO-6-DEOXY-ALPHA-D-GLUCOPYRANOSYL(1->4))-2-DEOXY-, SULPHATE (1:1) (SALT); Kanamycin sulfate; 25389-94-0; Kanamycin monosulfate; Kantrex; Kanamycin (sulfate); Kanamycin A monosulfate; 3847-27-6; MFCD00070253; 133-92-6; Kanamycin monosulfate [JAN]; Klebcil; Kanamycin Monosulphate; NSC-757068; D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-2-deoxy-, sulfate (1:1); Ophtalmokalixan; KANAMYCIN MONO SULFATE; C18H38N4O15S; Cristalomicina; Kanabristol; Kanamytrex; Otokalixin; Kanacedin; Kanaqua; Kanasig; Kanatrol; Kanescin; Kanicin; kanamycin sulfate monohydrate; Kano; Kanamycin sulfate [JAN]; UNII-J80EX28SMQ; Kanamycin sulfate [USP:JAN]; Kanamycin sulfate from Streptomyces kanamyceticus, Animal Component-free; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2H-pyran-3,4,5-triol sulfate; EINECS 246-933-9; Kantrex (TN); Kanamycini monosulfas; KANAMYCIN, SULFATE (1:1) (salt); First International Standard for Kanamycin; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol;sulfuric acid; Kanamycin sulfate (USP); Kanamycin monosulfate CRS; NCGC00016792-01; CAS-25389-94-0; CHEMBL1446; SCHEMBL65538; Kanamycin monosulfate (JP18); MSK7706B; orb1225507; orb1310286; orb3025425; HMS500B06; KUC109575AC; KANAMYCIN SULFATE [VANDF]; HMS2096O09; HMS3713O09; KANAMYCIN SULFATE [WHO-DD]; KSC-27-052C; Tox21_110612; Tox21_202817; HB4429; HY-16566A; s2315; AKOS025310124; KANAMYCIN SULFATE [GREEN BOOK]; AK11349; CCG-220394; CS-1140; EBC-101047; KANAMYCIN SULFATE [ORANGE BOOK]; NSC 757068; Kanamycin sulfate 100 |Ig/mL in Water; NCGC00260363-01; DA-54595; SY074485; Kanamycin sulfate 100 microg/mL in Water; K0047; Kanamycin Sulfate, Streptomyces kanamyceticus; NS00081901; C08046; D00866; K-0250; M02038; Kanamycin sulfate from Streptomyces kanamyceticus; C100081; EN300-19650841; Q27107073; Kanamycin sulfate, Antibiotic for Culture Media Use Only; Z3041518981; Kanamycin sulfate Streptomyces kanamyceticus, powder, gamma-irradiated; Kanamycin sulfate from Streptomyces kanamyceticus, meets USP testing specifications, powder; Kanamycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-bis(azanyl)-3-[(2S,3R,4S,5S,6R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol sulphate; (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol; sulfuric acid; .alpha.-D-Glucopyranoside, (1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-.alpha.-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-, sulfate (1:1) (salt); D-Streptamine, O-3-amino-3-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku6)-O-[6-amino-6-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku4)]-2-deoxy-, sulfate (1:1); D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1-4))-2-deoxy-, sulfate (1:1) (salt); Kanamycin sulfate from Streptomyces kanamyceticus, powder, BioReagent, suitable for cell culture, suitable for plant cell culture; O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine Monosulfate; Sulfuric acid--(1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside (1/1)동의어
Kanamycin A Sulfate 함유 제품
Kanamycin A Sulfate 판매 기업
LG
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.ChinaHT
Hebei Teamtop Pharmaceutical Co.,LtdChinaHV
Hangzhou Verychem Science And Technology Co.Ltd.ChinaGZ
Guangzhou Zohong Biotechnology Co., LtdChinaCS
Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd.China